Home/Filings/4/0000891293-17-000004
4//SEC Filing

CTI BIOPHARMA CORP 4

Accession 0000891293-17-000004

CIK 0000891293operating

Filed

Jan 2, 7:00 PM ET

Accepted

Jan 3, 7:21 PM ET

Size

4.8 KB

Accession

0000891293-17-000004

Insider Transaction Report

Form 4
Period: 2016-12-31
SEELEY BRUCE J.
EVP, Chief Commercial Officer
Transactions
  • Award

    Common Stock

    2016-12-31$0.30/sh+5,000$1,523310,000 total
Footnotes (1)
  • [F1]Shares acquired under the CTI BioPharma Corp. 2007 Employee Stock Purchase Plan. The number of shares purchased was before giving effect to the January 1, 2017 reverse stock split.

Issuer

CTI BIOPHARMA CORP

CIK 0000891293

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0000891293

Filing Metadata

Form type
4
Filed
Jan 2, 7:00 PM ET
Accepted
Jan 3, 7:21 PM ET
Size
4.8 KB